WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) announced its participation in two significant investor conferences in New York.
The management team will present at the H.C. Wainwright 26th Annual Global Investment Conference on September 9, 2024, at 8:00 am ET. The following day, they will host a fireside chat at the Baird Global Healthcare Conference at 8:30 am ET on September 10, 2024.
These events provide an opportunity for Arbutus to engage with investors and discuss its strategic initiatives.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.
READ: EPAM Systems Completes Acquisition of First Derivative to Enhance Financial Services Offerings